Using bar-code verification technology within an electronic medication administration system substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a new study.
Using bar-code verification technology within an electronic medication administration system (bar-code eMAR) substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a study from Brigham and Women's Hospital.
Investigators observed more than 14,000 medication administrations and reviewed more than 3,000 order transcriptions at Brigham and Women's Hospital.
In hospital units that did not use the bar-code eMAR, researchers observed 776 nontiming errors in medication administration (11.5% error rate) compared with 495 such errors (6.8% error rate) on units used the technology-a 41% relative reduction in errors (P<.001).
In addition, although transcription errors occurred at a rate of 6.1% on units without bar-code eMAR, they were completely eliminated on units that did use the technology.
Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362(18):1698-1707.
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More